Nichola Cooper/X
Sep 1, 2025, 15:32
British Journal of Haematology: US ITP Patient Survey on Platelet Management, Fatigue, and Support
British Journal of Haematology shared a post on X:
“US survey of ITP patients seeking better long-term disease management to improve/maintain platelet counts, minimize bleeding, reduce physical fatigue and anxiety, and increase patient support options ”
Title: Patient survey in immune thrombocytopenia (ITP): Identifyingunmet needs related to treatment and disease control in patientsliving in the United States
Authors: Nichola Cooper, Caroline Kruse, Sharon Deneen Morgan, Julie Laurent, Marleni Arvelo- Saillant, Jean-Pascal Roussy, Matias Cordoba, Imene Gouia, Lisa-Anne Schmitt, Erin Reineke, Terry Gernsheimer

Read the full paper here.
More recent insights on Hemostasis Today.
anxiety
bleeding disorders
British Journal of Haematology
Caroline Kruse
Erin Reineke
fatigue
Hematology
Hemostasis
Hemostasis Today
Imene Gouia
immune thrombocytopenia (ITP)
Jean-Pascal Roussy
Julie Laurent
Lisa-Anne Schmitt
Marleni Arvelo- Saillant
Matias Cordoba
Nichola Cooper
Patient survey
platelets
Sharon Deneen Morgan
Terry Gernsheimer
United States
-
Mar 6, 2026, 16:51Priya Reehal: Highlighting The Central Role of Nurses in Cardio-Oncology
-
Mar 6, 2026, 16:50Rainer Kaiser: Blinatumomab Shows Remarkable Response in Multi-Refractory ITP and APS
-
Mar 6, 2026, 16:18Laila Shalabi: Clopidogrel, Aspirin, and the Role of PPIs in Coronary Artery Disease
-
Mar 6, 2026, 16:17Paul McKenzie: The Value of Gene Therapy in Bleeding Disorders
-
Mar 6, 2026, 16:15Basma El Homasany: The ‘Little Brain’ of the Heart and Its Role in Health
-
Mar 6, 2026, 16:14Jamal Rana: Family History and Polygenic Risk for Coronary Heart Disease
-
Mar 6, 2026, 15:43Kristy Ainslie: Breaking Down the Discovery and FDA Approval of Drug Carriers
-
Mar 6, 2026, 15:18Claudio Laudani: Efficacy and Safety of Colchicine for Secondary Prevention in Coronary Artery Disease
-
Mar 6, 2026, 15:09Chris Simon: Persona PLUS Receives FDA Clearance for Patent‑Protected Plasma Apheresis